Bacterial proteases: current therapeutic use and future prospects for the development of new antibiotics
The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
Proteases of the serine-, cysteine- and metallo- type are widely spread in many pathogenic bacteria, where they play critical functions related to colonisation and evasion of host immune defences, acquisition of nutrients for growth and proliferation, facilitation of dissemination, or tissue damage during infection. Since all the antibiotics currently used clinically share a common mechanism of action, i.e., inhibition of bacterial cell wall biosynthesis, resistance to these pharmacological agents represents a serious medical problem, which might be resolved by using a new generation of antibiotics with a different mechanism of action. Bacterial protease inhibitors constitute an interesting possibility, due to the fact that many specific and ubiquitous proteases have recently been characterised in some detail in both Gram-positive and Gram-negative pathogens. Unfortunately, at this moment few potent, specific inhibitors for such bacterial proteases have been reported, except for signal peptidase, clostripain, Clostridium histolyticum collagenase, botulinum neurotoxin and tetanus neurotoxin inhibitors (but such protease inhibitors are not used clinically for the moment). No inhibitors of the critically important and ubiquitous AAA proteases, degP or sortase have been reported, although such compounds would presumably constitute a new class of highly effective antibiotics. On the other hand, several bacterial proteases, such as the Clostridium histolyticum collagenase, or the botulinum neurotoxin A possess therapeutic applications per se for the treatment of some diseases or for the preparation of vaccines. This review presents the state of the art in the design of such enzyme inhibitors with potential therapeutic applications, as well as recent advances in the use of some of these proteases in therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Navarre, W. W., & Schneewind, O. (1999) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.63.1.174-229.1999 · Cited by 1,391 · cited 2×
“These data clearly show that cell wall anchoring of surface proteins is a critical parameter for the development of staphylococcal infection and that sortase is a very promising target for the development of novel types of antibiotic effective against Gram-positive bacteria [100-107].”
BackgroundStaphylococcus aureus Sortase, an Enzyme that Anchors Surface Proteins to the Cell Wall
Mazmanian, S. K., Liu, G., Ton-That, H., & Schneewind, O. (1999) · Science · doi:10.1126/science.285.5428.760 · Cited by 1,053 · cited 3×
“These data clearly show that cell wall anchoring of surface proteins is a critical parameter for the development of staphylococcal infection and that sortase is a very promising target for the development of novel types of antibiotic effective against Gram-positive bacteria [100-107].”
BackgroundTon-That, H., Liu, G., Mazmanian, S. K., Faull, K. F., & Schneewind, O. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.22.12424 · Cited by 567 · cited 4×
“Sortase possesses both protease as well as transpeptidase activities [102,104], similarly to the Streptomyces K15 D-Ala-D-Ala transpeptidase and Streptomyces R61 D-Ala-D-Ala carboxypeptidase previously discussed.”
BackgroundMethodInfluentialMazmanian, S. K., Liu, G., Jensen, E. R., Lenoy, E., & Schneewind, O. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.080520697 · Cited by 453
Anchoring of Surface Proteins to the Cell Wall of Staphylococcus aureus
Ton-That, H., Mazmanian, S. K., Faull, K. F., & Schneewind, O. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.13.9876 · Cited by 359
Sortase, a universal target for therapeutic agents against Gram-positive bacteria?
Cossart, P., & Jonquières, R. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.10.5013 · Cited by 203
Structural and biochemical studies of retroviral proteases
Wlodawer, A., & Gustchina, A. (2000) · Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology · doi:10.1016/s0167-4838(99)00267-8 · Cited by 166 · cited 2×
“Although in the case of several viral proteases much success has recently been reported, mainly for the design of inhibitors of HIV proteases, in the case of the bacterial proteases (which, as can be seen from this review are widely distributed in pathogenic bacteria) this approach has rarely been taken into considera…”
BackgroundAnchor Structure of Staphylococcal Surface Proteins
Ton-That, H., & Schneewind, O. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.34.24316 · Cited by 140
Cited by
Dominy, S. S., Lynch, C., Ermini, F., Benedyk, M., Marczyk, A., Konradi, A., Nguyen, M., Haditsch, U., Raha, D., Griffin, C., et al. (2019) · Science Advances · doi:10.1126/sciadv.aau3333 · Cited by 1,966
Supuran, C. T., Scozzafava, A., & Casini, A. (2003) · Medicinal Research Reviews · doi:10.1002/med.10025 · Cited by 1,449
Self-citationIrreversible Inhibitors of Serine, Cysteine, and Threonine Proteases
Powers, J. C., Asgian, J. L., Ekici, Ö. D., & James, K. E. (2002) · Chemical Reviews · doi:10.1021/cr010182v · Cited by 1,090
Proteases and Delayed Wound Healing
McCarty, S. M., & Percival, S. L. (2013) · Advances in Wound Care · doi:10.1089/wound.2012.0370 · Cited by 476
McCarty, S. M., Cochrane, C. A., Clegg, P. D., & Percival, S. L. (2012) · Wound Repair and Regeneration · doi:10.1111/j.1524-475x.2012.00763.x · Cited by 193
Metadata
- Authors
- Supuran, C. T., Scozzafava, A., & Mastrolorenzo, A.
- Venue
- Expert Opinion on Therapeutic Patents
- Publisher
- Informa Healthcare
- Published
- 2001-02
- Volume
- 11
- Issue
- 2
- Pages
- 221-259
- ISSN
- 1354-3776 (ISSN-L)
- 1744-7674
- OpenAlex
- W2124438931
- Cited by
- 115
- References
- 8
- FWCI
- 1.65
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.